ArticleJournal of nanobiotechnology2026
Mechano-reprogramming of tumor-associated macrophages by engineering nanogel stiffness for suppression of tumor development.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Nanoparticle mechanical properties, as critical factors in tumor targeting drug delivery, have recently been revealed to regulate cellular biological functions. While macroscopic mechanical stimuli are demonstrated to reprogram tumor-associated macrophages (TAMs), it is unclear how TAMs respond to microscopic stimuli from nanoparticles. Herein, we demonstrated that the stiff 15%NGs presented stronger interactions with integrin than the soft 2%NGs, promoting the polymerization of actin and the activation of yes-associated protein 1. Therefore, the pro-inflammatory phenotype of TAMs was enhanced and the secretion of tumor necrosis factor α was increased. In synergy with high liver enrichment, 15%NGs exhibited superior tumor suppression by reprogramming TAMs in orthotopic liver tumors. Crucially, the pro-inflammatory phenotype of macrophages reprogrammed by 15%NGs significantly induced the apoptosis of tumor cells in ex vivo hepatocellular carcinoma tissues from patients. This study proposes a mechanical signaling pathway to reprogram TAMs by manipulating nanogel stiffness and provides new insights for rational design of cancer nanomedicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.